Insilico Medicine Advances AI-Designed PRMT5 Inhibitor ISM0387 for Glioblastoma with Sub-12-Month Discovery Timeline
Insilico Medicine (HKG: 3696), a China-based artificial intelligence (AI) drug discovery platform, announced the selection...
R&D
Ascletis Selects ASC37 as Clinical Candidate for Monthly Triple Agonist Therapy
Ascletis Pharma Inc. (HKG: 1672) announced it has selected ASC37, a next‑generation once‑monthly subcutaneous GLP‑1R/GIPR/GCGR triple‑agonist...
Insilico Medicine Partners with Servier on $888 Million AI Oncology Deal
Insilico Medicine (HKG: 3696) announced a multi‑year R&D collaboration with Servier to identify and develop...
Bio-Sincerity UCAS R&D Center Pharma Synthesis
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (SHE: 301096) announced the signing of a cooperation agreement with...
Simcere Halts R&D on Alzheimer’s Drug Candidates Amid Pipeline Setbacks
Simcere Pharmaceutical Group (HKG: 2096) has reportedly discontinued research and development of its Alzheimer’s disease...
Ascletis Pharma’s ASC47 Outperforms Semaglutide in Weight Loss Study
China-based Ascletis Pharma Inc. (HKG: 1672) has announced encouraging results from a study on its...
Legend Biotech Corporation to Establish Advanced R&D Center in Philadelphia for Next-Generation Cell Therapies
Legend Biotech Corporation (NASDAQ: LEGN), a leading chimeric antigen receptor (CAR) T cell therapy specialist...
Bayer AG Launches New Life Sciences Incubator in Shanghai to Boost Biotech Ecosystem
Bayer AG (ETR: BAYN, FRA: BAYN, OTCMKTS: BAYRY), a leading German life sciences company, announced...
Global Researchers Call for the Revival of the Human Genome Project to Advance Precision Medicine
A consortium of international researchers, spearheaded by a team from China’s gene sequencing giant BGI,...
Oxford Nanopore Sets Sights on BGI in UK Courts Over Nanopore Sequencing Technology
Oxford Nanopore Technologies plc (LON: ONT), a UK-based leader in nanopore sequencing technology, has disclosed...
Tigermed Partners with Purpose Africa to Boost Clinical Research and Healthcare Cooperation
Tigermed (SHE: 300347), a leading Contract Research Organization (CRO) in China, has entered into a...
Eli Lilly Partners with Haya Therapeutics to Tap the Dark Genome for Obesity Treatments
Eli Lilly & Co. (NYSE: LLY), a leading figure in the pharmaceutical industry, has embarked...
US Allows Science and Technology Agreement with China to Expire, Pointing to Deepening R&D Competition
The US-China Science and Technology Agreement (STA), a pivotal accord initially inked in 1979 by...
Baheal Pharmaceutical Group to Establish R&D Center for Myocardial Repair with CAMS Fuwai Hospital
BEIJING—Baheal Pharmaceutical Group, a leading healthcare services and distribution company in China, is venturing into...
American Government Funds Bolster Chinese Inventors’ Patents, According to USPTO Data
WASHINGTON—A Reuters investigation into the United States Patent and Trademark Office (USPTO) data has uncovered...
New Agreement Enhances Myopia Solutions: Hong Kong Polytechnic and Zeiss Collaborate
The School of Optometry at Hong Kong Polytechnic University has announced a new cooperation agreement...
HuidaGene Secures Patent for Innovative CRISPR-Cas12i System in China
HuidaGene (Shanghai) Biotechnology Co., Ltd, a China-based biotech firm, has secured patent approval from the...
Wondfo Biotech and University of Science, Malaysia Deepen Ties with Formal Partnership
Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482), a biotechnology firm based in China, has formalized...
Shanghai Pharmaceuticals’ SH-INNO Incubator to Drive Biopharmaceutical Innovation and Collaboration
Shanghai Pharmaceuticals (SPH;HKG: 2607; SHA: 601607) has launched the “SH-INNO incubator,” a collaborative initiative with...
CNBG and University of Macau Ink Deal to Establish Joint Biotech Lab
China National Biotec Group Company Ltd (CNBG) has announced a strategic collaboration with the University...